West introduces daikyo plascap® ruv closures in new nested format at pharmapack

Exton, pa. , jan. 22, 2025 /prnewswire/ -- west pharmaceutical services, inc. (nyse: wst), a global leader in innovative solutions for injectable drug administration, today announced the introduction of daikyo plascap® ready-to-use validated (ruv) closures in a new nested format available in multiple configurations at this year's pharmapack event in paris, france.  this marks west's latest product offering supporting the needs of advanced therapies, one of the fastest growing areas, driven by continued innovation in cell and gene therapy treatments.
WST Ratings Summary
WST Quant Ranking